3D facial analysis for rare disease diagnosis and treatment monitoring: Proof-Of-Concept plan for hereditary angioedema.
Journal
PLOS digital health
ISSN: 2767-3170
Titre abrégé: PLOS Digit Health
Pays: United States
ID NLM: 9918335064206676
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
05
08
2022
accepted:
24
01
2023
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
23
3
2023
Statut:
epublish
Résumé
Rare diseases pose a diagnostic conundrum to even the most experienced clinicians around the world. The technology could play an assistive role in hastening the diagnosis process. Data-driven methodologies can identify distinctive disease features and create a definitive diagnostic spectrum. The healthcare professionals in developed and developing nations would benefit immensely from these approaches resulting in quicker diagnosis and enabling early care for the patients. Hereditary Angioedema is one such rare disease that requires a lengthy diagnostic cascade ensuing massive patient inconvenience and cost burden on the healthcare system. It is hypothesized that facial analysis with advanced imaging and algorithmic association can create an ideal diagnostic peer to the clinician while assimilating signs and symptoms in the hospital. 3D photogrammetry has been applied to diagnose rare diseases in various cohorts. The facial features are captured at a granular level in utmost finer detail. A validated and proven algorithm-powered software provides recommendations in real-time. Thus, paving the way for quick and early diagnosis to well-trained or less trained clinicians in different settings around the globe. The generated evidence indicates the strong applicability of 3 D photogrammetry in association with proprietary Cliniface software to Hereditary Angioedema for aiding in the diagnostic process. The approach, mechanism, and beneficial impact have been sketched out appropriately herein. This blueprint for hereditary angioedema may have far-reaching consequences beyond disease diagnosis to benefit all the stakeholders in the healthcare arena including research and new drug development.
Identifiants
pubmed: 36947507
doi: 10.1371/journal.pdig.0000090
pii: PDIG-D-22-00209
pmc: PMC10032512
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000090Informations de copyright
Copyright: © 2023 Jamuar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Med Genet. 1987 Aug;24(8):509-10
pubmed: 3656376
J Med Internet Res. 2020 Mar 6;22(3):e15065
pubmed: 32141835
Immunol Allergy Clin North Am. 2017 Aug;37(3):597-616
pubmed: 28687112
NPJ Digit Med. 2021 Sep 3;4(1):129
pubmed: 34480109
J Inherit Metab Dis. 2018 May;41(3):533-539
pubmed: 29623569
Orthod Craniofac Res. 2009 Aug;12(3):212-20
pubmed: 19627523
Genet Med. 2020 Oct;22(10):1682-1693
pubmed: 32475986
Curr Opin Pediatr. 2018 Dec;30(6):701-706
pubmed: 30407972
Genet Med. 2019 Aug;21(8):1781-1789
pubmed: 30568310
Clin Rev Allergy Immunol. 2016 Oct;51(2):162-9
pubmed: 27113957
Plast Reconstr Surg. 2015 May;135(5):1295-1304
pubmed: 25835245
Am J Gastroenterol. 2006 Mar;101(3):619-27
pubmed: 16464219
Quintessence Int. 2021 Jul 20;52(8):694-704
pubmed: 34076383
JIMD Rep. 2013;8:31-9
pubmed: 23430517
J Med Genet. 2022 Oct;59(10):938-946
pubmed: 34916229
Twin Res Hum Genet. 2013 Aug;16(4):840-4
pubmed: 23870680
Nat Med. 2019 Jan;25(1):60-64
pubmed: 30617323
Clin Rev Allergy Immunol. 2016 Oct;51(2):230-9
pubmed: 27388236
JAMA. 2014 Nov 12;312(18):1870-9
pubmed: 25326635
Clin Rev Allergy Immunol. 2021 Jun;60(3):404-415
pubmed: 33560480
Congenit Heart Dis. 2014 Mar-Apr;9(2):144-50
pubmed: 23750712
Front Public Health. 2017 Apr 10;5:31
pubmed: 28443272
Hosp Pediatr. 2021 Mar;11(3):e38-e41
pubmed: 33632747
Elife. 2014 Jun 24;3:e02020
pubmed: 24963138
Allergy Asthma Clin Immunol. 2021 Apr 19;17(1):40
pubmed: 33875020
Ther Clin Risk Manag. 2016 May 02;12:701-11
pubmed: 27194914
J Clin Sleep Med. 2020 Apr 15;16(4):493-502
pubmed: 32003736
JAMA Netw Open. 2020 Nov 2;3(11):e2022199
pubmed: 33206189
Nat Rev Drug Discov. 2020 Feb;19(2):77-78
pubmed: 32020066
Clin Pediatr (Phila). 2016 Sep;55(10):935-42
pubmed: 26581355
Ann Allergy Asthma Immunol. 2016 Oct;117(4):394-398
pubmed: 27742086